The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.830
-0.130 (-4.39%)
At close: Mar 30, 2026, 4:00 PM EDT
2.830
0.00 (0.00%)
After-hours: Mar 30, 2026, 4:10 PM EDT

Company Description

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States.

It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.

It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.

It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

The Oncology Institute, Inc.
The Oncology Institute logo
CountryUnited States
Founded2007
IndustryMedical Care Facilities
SectorHealthcare
Employees641
CEODaniel Virnich

Contact Details

Address:
18000 Studebaker Road, Suite 800
Cerritos, California 90703
United States
Phone562 735 3226
Websitetheoncologyinstitute.com

Stock Details

Ticker SymbolTOI
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code1799191
CUSIP Number68236X100
ISIN NumberUS68236X1000
Employer ID84-3562323
SIC Code8011

Key Executives

NamePosition
Dr. Daniel Virnich FACHE, M.B.A., M.D.Chief Executive Officer and Executive Director
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.Chief Medical Officer
Robert CarterChief Financial Officer
Austin LeeVice President of Accounting and Controller
Rakesh PandaChief Information Officer
Kristin EnglandChief Administrative Officer
Mark Hueppelsheuser Esq.General Counsel
Nolan MarianoChief People Officer
Jordan McInerneyChief Development Officer
Stephen CellaSenior Vice President of Finance

Latest SEC Filings

DateTypeTitle
Mar 16, 2026SCHEDULE 13G/AFiling
Mar 13, 20268-KCurrent Report
Mar 12, 202610-KAnnual Report
Mar 12, 20268-KCurrent Report
Feb 23, 20268-KCurrent Report
Jan 15, 2026SCHEDULE 13GFiling
Jan 12, 20268-KCurrent Report
Jan 7, 20268-KCurrent Report
Dec 15, 2025144Filing
Dec 1, 20258-KCurrent Report